Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1
- PMID: 11473421
- DOI: 10.1021/np010049y
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1
Abstract
The potent antitumor agent dolastatin 10 (1) was originally isolated from the sea hare Dolabella auricularia, and we now report its isolation from the marine cyanobacterium Symploca sp. VP642 from Palau. The chemically related analogue symplostatin 1 (2) has been reisolated from Guamanian and Hawaiian varieties of S. hydnoides and its total stereochemistry completed by determining the N,N-dimethylisoleucine unit to be L. Symplostatin 1 (2), like dolastatin 10 (1), is a potent microtubule inhibitor. The antitumor activity of 2 was assessed in vivo against several murine tumors. Symplostatin 1 (2) was effective against a drug-insensitive mammary tumor and a drug-insensitive colon tumor; however, it was only slightly effective against two MDR tumors.
Similar articles
-
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.J Nat Prod. 1998 Sep;61(9):1075-7. doi: 10.1021/np980321c. J Nat Prod. 1998. PMID: 9748368
-
Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.J Nat Prod. 1999 Apr;62(4):655-8. doi: 10.1021/np980553b. J Nat Prod. 1999. PMID: 10217737
-
Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.J Nat Prod. 2002 Jan;65(1):16-20. doi: 10.1021/np010317s. J Nat Prod. 2002. PMID: 11809057
-
The cyanobacterial origin of potent anticancer agents originally isolated from sea hares.Curr Med Chem. 2002 Oct;9(20):1791-806. doi: 10.2174/0929867023369051. Curr Med Chem. 2002. PMID: 12369878 Review.
-
The dolastatins, a family of promising antineoplastic agents.Curr Pharm Des. 1999 Mar;5(3):139-62. Curr Pharm Des. 1999. PMID: 10066887 Review.
Cited by
-
The Chemotherapeutic Potentials of Compounds Isolated from the Plant, Marine, Fungus, and Microorganism: Their Mechanism of Action and Prospects.J Trop Med. 2022 Oct 10;2022:5919453. doi: 10.1155/2022/5919453. eCollection 2022. J Trop Med. 2022. PMID: 36263439 Free PMC article. Review.
-
Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.Angew Chem Int Ed Engl. 2013 Jul 8;52(28):7098-124. doi: 10.1002/anie.201208344. Epub 2013 May 31. Angew Chem Int Ed Engl. 2013. PMID: 23729217 Free PMC article. Review.
-
Enhancing Human Health and Wellbeing through Sustainably and Equitably Unlocking a Healthy Ocean's Potential.Ann Glob Health. 2024 Jul 9;90(1):41. doi: 10.5334/aogh.4471. eCollection 2024. Ann Glob Health. 2024. PMID: 39005643 Free PMC article.
-
Hoiamide a, a sodium channel activator of unusual architecture from a consortium of two papua new Guinea cyanobacteria.Chem Biol. 2009 Aug 28;16(8):893-906. doi: 10.1016/j.chembiol.2009.06.012. Chem Biol. 2009. PMID: 19716479 Free PMC article.
-
Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF-1α Mediated Cancer Cell Viability and Vascularization.Chembiochem. 2020 Aug 17;21(16):2356-2366. doi: 10.1002/cbic.202000180. Epub 2020 May 12. Chembiochem. 2020. PMID: 32237262 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
